中文

BIO-TECHNE Corp Revenue Breakdown

Period 2026-03-31 (quarterly) ・ Reported 2026-05-06
ItemAmountY/Y
Revenue$0.31B-1.5%
Gross profit$0.21B
Operating income$0.08B
Net income$0.05B+126.0%
Gross margin66.9%Net margin 16.4%
Revenue Q/Q+5.3%

Revenue Segments

SegmentRevenueShare
Consumables$0.26B82.6%
Instruments$0.03B8.9%
Service$0.02B6.9%
Royalty$0.00B1.6%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue$0.10B33.1%
SG&A$0.11B35.1%
Tax & other$0.02B7.9%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

BIIBBLKBXXYZBNYBABKNGBSXBMYAVGOBRBRO

Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies